Lifeward stock price target raised to $10 on partnership strength

try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Brent oil hovers near $115 after retreating from earlier spike amid supply fears What happens next in Hormuz? ING outlines three scenarios European stocks lower amid central bank decisions, oil prices surge Gold prices pinned below $4,900/oz as rate uncertainty dulls safe haven appeal FLASH SALE (South Africa Philippines Nigeria) FLASH SALE Lifeward stock price target raised to $10 on partnership strength By Analyst Ratings Published 03/19/2026, 07:45 AM Lifeward stock price target raised to $10 on partnership strength 0 ORMP -1.11% LFWD -11.11% Investing.com - H.C. Wainwright raised its price target on Lifeward (NASDAQ:LFWD) to $10.00 from $4.50 while maintaining a Buy rating on the stock. The new target implies nearly 49% upside from the current price of $6.72, while InvestingPro analysis suggests the stock is undervalued with a Fair Value of $11.14. The firm cited the company’s operational turnaround under new leadership through strategic transactions entered into since early 2026. In early January, Lifeward entered into a partnership with Oramed that includes acquisition of Oramed ’s POD technology and cash infusion up to $47 million. In exchange, Oramed is expected to receive a 49.99% equity ownership interest in Lifeward. Oramed plans to fund and manage clinical development of ORMD-0801, an oral insulin candidate for Type 2 Diabetes that was developed using POD technology. H.C. Wainwright said it expects the transaction to close soon. The firm’s financial model does not account for revenues associated with ORMD-0801 or POD technology as it waits for management to provide insight into development and commercial plans. The firm said it is encouraged by the transaction as it helps strengthen the balance sheet and provide a novel oral delivery technology. An InvestingPro tip notes that while Lifeward holds more cash than debt on its balance sheet, the company is quickly burning through cash—making the $47 m...